The scientist’s investigation covers issues in Internal medicine, Acquired immunodeficiency syndrome, Immunology, Viral load and Pharmacology. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Surgery. His study in Acquired immunodeficiency syndrome is interdisciplinary in nature, drawing from both Epidemiology, Viral disease, Prospective cohort study, Pediatrics and Risk factor.
His Immunology study combines topics in areas such as Odds ratio, Cohort study, Pneumonia, Proportional hazards model and Disease. The concepts of his Viral load study are interwoven with issues in Drug resistance and Maraviroc. His Pharmacology research includes themes of Elvitegravir, Clinical trial, Integrase inhibitor, Ritonavir and Raltegravir.
His primary areas of investigation include Internal medicine, Acquired immunodeficiency syndrome, Immunology, Virology and Gastroenterology. His Internal medicine study combines topics from a wide range of disciplines, such as Surgery and Viral load. His work carried out in the field of Viral load brings together such families of science as Efavirenz and Pharmacology.
His Acquired immunodeficiency syndrome research is multidisciplinary, incorporating perspectives in Viral disease, Incidence, Epidemiology and Pediatrics. His research related to Immunopathology and Antibody might be considered part of Immunology. His research in Virology tackles topics such as Protease inhibitor which are related to areas like Ritonavir.
The scientist’s investigation covers issues in Internal medicine, Pharmacology, Viral load, Virology and Immunology. The Internal medicine study combines topics in areas such as Gastroenterology and Efavirenz. The various areas that he examines in his Pharmacology study include Protease inhibitor, Etravirine, Darunavir, Confidence interval and Ritonavir.
His study focuses on the intersection of Virology and fields such as Human papillomavirus with connections in the field of HPV infection. His work deals with themes such as Transmission, Viral suppression, Logistic regression and Acquired immunodeficiency syndrome, which intersect with Immunology. His Acquired immunodeficiency syndrome research includes elements of Tuberculosis, Pharmacotherapy, Public health, Pediatrics and Cohort.
Nathan Clumeck mainly focuses on Internal medicine, Pharmacology, Immunology, Viral load and Efavirenz. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Emtricitabine. His Gastroenterology research incorporates elements of Adverse effect and Hepatitis C virus.
The concepts of his Immunology study are interwoven with issues in Acquired immunodeficiency syndrome, Anal cancer, Disease, Public health and Prospective cohort study. The subject of his Viral load research is within the realm of Virology. His Efavirenz study also includes
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study
Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)
CD4+ count-guided interruption of antiretroviral treatment.
Wafaa El-Sadr;Wafaa El-Sadr;Jens D Lundgren;James Neaton;Fred Gordin.
The New England Journal of Medicine (2006)
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
Richard K. Sterling;Eduardo Lissen;Eduardo Lissen;Nathan Clumeck;Ricard Sola.
Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
Roy M. Gulick;Jacob Lalezari;James Goodrich;Nathan Clumeck.
The New England Journal of Medicine (2008)
Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection
Sharon L. Walmsley;Antonio Antela;Nathan Clumeck;Dan Duiculescu.
The New England Journal of Medicine (2013)
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults
N Clumeck;A Pozniak;F Raffi.
Hiv Medicine (2008)
Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients.
Alfredo Alberti;Nathan Clumeck;Simon Collins;Wolfram Gerlich.
Journal of Hepatology (2005)
Acquired Immunodeficiency Syndrome in Rwanda
Philippe Van De Perre;Philippe Lepage;Philippe Kestelyn;AntonC. Hekker.
The Lancet (1984)
Isolation of aids virus from cell-free breast milk of three healthy virus carriers
L. Thiry;S. Sprecher-Goldberger;T. Jonckheer;J. Levy.
The Lancet (1985)
Treatment of Toxoplasmic Encephalitis in Patients with AIDS: A Randomized Trial Comparing Pyrimethamine plus Clindamycin to Pyrimethamine plus Sulfadiazine
B Dannemann;J A McCutchan;D Israelski;D Antoniskis.
Annals of Internal Medicine (1992)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: